Planmed explores full-field digital
This Finnish company (Hall B, #7142) is developing a full-field digital mammography system that it plans to offer as a retrofit to its installed base of Sophie screening units. Sophie Digital uses charge-coupled device (CCD) technology and a
This Finnish company (Hall B, #7142) is developing a full-field digital mammography system that it plans to offer as a retrofit to its installed base of Sophie screening units. Sophie Digital uses charge-coupled device (CCD) technology and a slot-scanning architecture, with resolution of 17 line pairs/mm and a field-of-view of 24 x 30 cm. Planmed hopes to start clinical trials of the system next year in preparation for a regulatory submission to the FDA.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
Emerging AI Mammography Model May Enhance Clarity for Initial BI-RADS 3 and 4 Classifications
May 21st 2025In a study involving over 12,000 Asian women, researchers found that an artificial intelligence (AI) model converted over 83 percent of false positives in patients with initial BI-RADS 3 and 4 assessments into benign BI-RADS categories.
